SPARCL1 expression was elevated in PDAC samples compared to the normal tissue and PC cell lines, and its expression was found to be downregulated in the late stages of PC indicating the role of SPARCL1 as a tumor suppressor gene (Figure 3) [79]. The gene discussed is SPARCL1; the disease is pachyonychia congenita.